RU2008143055A - Ингибиторы ренина, предназначенные для гипертензии - Google Patents

Ингибиторы ренина, предназначенные для гипертензии Download PDF

Info

Publication number
RU2008143055A
RU2008143055A RU2008143055/14A RU2008143055A RU2008143055A RU 2008143055 A RU2008143055 A RU 2008143055A RU 2008143055/14 A RU2008143055/14 A RU 2008143055/14A RU 2008143055 A RU2008143055 A RU 2008143055A RU 2008143055 A RU2008143055 A RU 2008143055A
Authority
RU
Russia
Prior art keywords
renin inhibitor
administration
hypertension
antihypertensive effect
cancellation
Prior art date
Application number
RU2008143055/14A
Other languages
English (en)
Russian (ru)
Inventor
Эндрью САТЛИН (US)
Эндрью САТЛИН
Original Assignee
Новартис АГ (CH)
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38420678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2008143055(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новартис АГ (CH), Новартис Аг filed Critical Новартис АГ (CH)
Publication of RU2008143055A publication Critical patent/RU2008143055A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2008143055/14A 2006-04-03 2007-03-30 Ингибиторы ренина, предназначенные для гипертензии RU2008143055A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78884206P 2006-04-03 2006-04-03
US60/788,842 2006-04-03

Publications (1)

Publication Number Publication Date
RU2008143055A true RU2008143055A (ru) 2010-05-10

Family

ID=38420678

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008143055/14A RU2008143055A (ru) 2006-04-03 2007-03-30 Ингибиторы ренина, предназначенные для гипертензии

Country Status (20)

Country Link
US (1) US20090062395A1 (https=)
EP (1) EP2004167A1 (https=)
JP (1) JP2009532494A (https=)
KR (1) KR20080108515A (https=)
CN (1) CN101415413A (https=)
AU (1) AU2007234917B2 (https=)
BR (1) BRPI0710095A2 (https=)
CA (1) CA2645260A1 (https=)
CL (1) CL2007000912A1 (https=)
IL (1) IL193905A0 (https=)
MA (1) MA30387B1 (https=)
MX (1) MX2008012729A (https=)
NO (1) NO20084625L (https=)
NZ (1) NZ571251A (https=)
RU (1) RU2008143055A (https=)
SG (1) SG170830A1 (https=)
TN (1) TNSN08383A1 (https=)
TW (1) TW200806283A (https=)
WO (1) WO2007118023A1 (https=)
ZA (1) ZA200807615B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087116A1 (en) * 2008-01-11 2009-07-16 Novartis Ag Use of spp100 for the treatment of acute mi
CN102212012A (zh) * 2010-04-12 2011-10-12 上海源力生物技术有限公司 一种合成阿利克伦的中间体及其制备方法
WO2013057313A1 (en) 2011-10-20 2013-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the detection and the treatment of cardiac remodeling
CA3137138A1 (en) * 2019-04-18 2020-10-22 EyePoint Pharmaceuticals, Inc. Methods of treating hypertension with activators of tie-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
CA2490811A1 (en) * 2002-06-28 2004-01-08 Novartis Ag Use of organic compounds
WO2004100871A2 (en) * 2003-05-09 2004-11-25 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
PE20142101A1 (es) * 2004-03-17 2014-12-27 Novartis Ag Composiciones farmaceuticas de aliskiren
CA2581927C (en) * 2004-09-27 2013-04-09 Pantarhei Bioscience B.V. Treatment or prevention of unscheduled bleeding in women on progestogen containing medication

Also Published As

Publication number Publication date
BRPI0710095A2 (pt) 2011-08-02
JP2009532494A (ja) 2009-09-10
TNSN08383A1 (en) 2009-12-29
CN101415413A (zh) 2009-04-22
TW200806283A (en) 2008-02-01
AU2007234917A1 (en) 2007-10-18
MX2008012729A (es) 2008-10-14
AU2007234917B2 (en) 2011-05-12
MA30387B1 (fr) 2009-05-04
NO20084625L (no) 2008-11-03
IL193905A0 (en) 2009-08-03
CA2645260A1 (en) 2007-10-18
CL2007000912A1 (es) 2008-03-14
NZ571251A (en) 2011-12-22
SG170830A1 (en) 2011-05-30
KR20080108515A (ko) 2008-12-15
US20090062395A1 (en) 2009-03-05
ZA200807615B (en) 2009-10-28
WO2007118023A1 (en) 2007-10-18
EP2004167A1 (en) 2008-12-24

Similar Documents

Publication Publication Date Title
RU2012118974A (ru) Комбинации ингибитора pi3k и ингибитора мек
RU2015110240A (ru) Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия
KR20100057704A (ko) 발사르탄 및 ｎｅｐ 저해제를 포함하는 제약학적 조성물
FI3972603T3 (fi) Menetelmiä sjögrenin oireyhtymän hoitamiseksi käyttäen brutonin tyrosiinikinaasin estäjää
RU2013155509A (ru) Применение ингибирования катепсина к для лечения и/или профилактики легочной гипертензии и/или сердечной недостаточности
RU2008143055A (ru) Ингибиторы ренина, предназначенные для гипертензии
CA2291160C (en) Combination therapy for modulating the human sexual response
EP3132803B1 (en) Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
PT1487424E (pt) 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-il-amino)fenil]-benzamida para o tratamento doenças mediadas por ang ii
EP3820470B1 (en) Alkoxy pyrazoles as soluble guanylate cyclase activators for use in treating portal hypertension
US20150005506A1 (en) Therapeutic agent for diabetes
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
JP2019531286A5 (https=)
JP2025503015A5 (https=)
JPS59206309A (ja) 急発作障害の処置及びそれに有用な製薬組成物
FI3648761T3 (fi) Telmisartaani kissan hypertension ehkäisemiseksi tai hoitamiseksi
US20080051438A1 (en) Preventive/Therapeutic Compositions Useful for Treating Cardiovascular Diseases
NO20044568L (no) Fremgangsmate for inhibering av atrofi eller for behandling eller forhindring av atrofi-relaterte symptomer i kvinner
JP2009532494A5 (https=)
CN111065389B (zh) 治疗自身免疫性微脉管疾病的方法
MX2012015040A (es) Agente terapeutico de liberacion sostenida para la hipertension y la disfuncion renal.
Wong et al. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: current status
US20060128719A1 (en) Use of alpha-adrenergic blockers for the treatment of dysmenorrhea
WO2023003416A1 (ko) 전신경화증의 예방 또는 치료용 약학적 조성물
TWI354553B (en) Drug for glomerular diseases